This revised proposal is from a well established investigator who has made seminal contributions to the field of insulin action and now to the field of beta cell physiology. This proposal is based on recent data generated by the principal investigator using gene ablation in mice of IRS1 and IRS2, in combination with mice lacking one allele of the IGF-1 receptor. These data, recently published in Nature Genetics, strongly suggest that IRS2 is a key determinant of pancreatic beta cell development and that IGF-1 signaling in beta cells is largely through IRS2. The data further implicate IGF-1 signaling through IRS2 as a primary pathway that is required for an optimal complement of beta cells to develop. This application will extend these findings to determine underlying mechanisms for these hypothetical relationships. First, examination of tissue sections of embryo and adult mouse pancreas will be conducted to test the hypothesis that IRS2 is critical for proliferation and survival of islet precursor cells and identify the major site of developmental failure in mice lacking IRS2 protein. Second, the role of PI 3-kinase in mediating some of the effects of IRS2 in beta cell development will be examined. Third, experiments will be conducted to determine whether it is in fact the IRS2 lacking specifically in beta cells that causes diabetes in IRS2 gene knockout mice. IRS2 will be reintroduced into these animals, specifically in beta cells, and its effect on the diabetes syndrome monitored. Finally, disruption of IRS2 protein expression specifically in beta cells will be conducted to determine whether this is sufficient to cause diabetes, and specific hepatic disruption of IRS2 will be achieved as a presumed negative control.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Endocrinology Study Section (END)
Program Officer
Silva, Corinne M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Joslin Diabetes Center
United States
Zip Code
Copps, Kyle D; Hançer, Nancy J; Qiu, Wei et al. (2016) Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase. J Biol Chem 291:8602-17
Hançer, Nancy J; Qiu, Wei; Cherella, Christine et al. (2014) Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. J Biol Chem 289:12467-84
Sadagurski, Marianna; Dong, X Charlie; Myers Jr, Martin G et al. (2014) Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis. Mol Metab 3:55-63
Sadagurski, Marianna; Leshan, Rebecca L; Patterson, Christa et al. (2012) IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. Cell Metab 15:703-12
Cheng, Zhiyong; White, Morris F (2011) Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 14:649-61
Sadagurski, Marianna; Cheng, Zhiyong; Rozzo, Aldo et al. (2011) IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest 121:4070-81
Zaret, Kenneth S; White, Morris F (2010) Diabetes forum: Extreme makeover of pancreatic alpha-cells. Nature 464:1132-3
Cheng, Zhiyong; Tseng, Yolanda; White, Morris F (2010) Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21:589-98
Cheng, Zhiyong; White, Morris F (2010) Foxo1 in hepatic lipid metabolism. Cell Cycle 9:219-20
Norquay, Lisa D; D'Aquino, Katharine E; Opare-Addo, Lynn M et al. (2009) Insulin receptor substrate-2 in beta-cells decreases diabetes in nonobese diabetic mice. Endocrinology 150:4531-40

Showing the most recent 10 out of 21 publications